Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoplastic left heart syndrome.

L L Bailey1, S R Gundry

  • 1Department of Surgery, Loma Linda University Medical Center, California.

Pediatric Clinics of North America
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conservation genomics of an endangered montane amphibian reveals low population structure, low genomic diversity and selection pressure from disease.

Molecular ecology·2023
Same author

Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE).

Mutation research·2001
Same author

Concomitant traumatic coronary artery and tricuspid valve injury: a heterogeneous presentation.

The Journal of trauma·2001
Same author

Pediatric cardiac retransplantation: intermediate-term results.

The Annals of thoracic surgery·2001
Same author

Late rejection is a predictor of transplant coronary artery disease in children.

Journal of the American College of Cardiology·2001
Same author

Should children with severe cognitive impairment receive solid organ transplants?

The Journal of clinical ethics·2000
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

New surgical strategies offer hope for Hypoplastic Left Heart Syndrome (HLHS) patients, improving survival and quality of life beyond traditional "do nothing" approaches. These advanced treatments provide better long-term outcomes for complex congenital heart defects.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Surgical Innovation

Background:

  • Hypoplastic Left Heart Syndrome (HLHS) is a severe congenital heart defect affecting left ventricular development.
  • Historically, untreated HLHS has a very poor prognosis, with survival beyond infancy being rare.

Purpose of the Study:

  • To evaluate the efficacy of newer surgical strategies for HLHS.
  • To compare outcomes of staged palliative reconstruction (Fontan procedure) versus heart transplantation.
  • To assess the long-term functional capacity and quality of life in HLHS survivors.

Main Methods:

  • Review of outcomes following staged palliative reconstruction (e.g., Fontan procedure).
  • Analysis of results from heart transplantation in HLHS patients.

Related Experiment Videos

  • Comparison of exercise tolerance, work capacity, and medication requirements between treatment groups.

    • Main Results:

    • Fontan procedure survivors often achieve NYHA Class I or II functional status without medication.
    • Heart transplant recipients require lifelong immunosuppression but demonstrate better exercise capability and near-normal ejection fractions.
    • Fontan procedure results in 40-60% of normal exercise tolerance, with full functional capacity potentially not normalized.

    Conclusions:

    • Modern surgical interventions for HLHS are significantly more effective than the traditional
    • do nothing
    • approach.
    • Both staged palliation and heart transplantation offer promising, albeit different, long-term benefits for HLHS patients.
    • Continued advancements in surgical management are crucial for improving outcomes in HLHS.